Vyvanse and Spiriva respimat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyvanse (lisdexamfetamine dimesylate) and Spiriva respimat (tiotropium bromide). Common drug interactions include dyspnoea among females and anaphylactic reaction among males.

The phase IV clinical study analyzes what interactions people have when they take Vyvanse and Spiriva respimat. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Vyvanse?

Vyvanse has active ingredients of lisdexamfetamine dimesylate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 35,868 Vyvanse users. Check the latest studies of Vyvanse.

What is Spiriva respimat?

Spiriva respimat has active ingredients of tiotropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 9,788 Spiriva respimat users. Check the latest studies of Spiriva respimat.

On Jul, 18, 2026

15 people who take Vyvanse and Spiriva respimat together, and have interactions are studied.

Vyvanse and Spiriva respimat drug interactions.

What are the common drug interactions of Vyvanse and Spiriva Respimat, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Constipation
Blood immunoglobulin g increased
Ear infection
Influenza
Oropharyngeal pain
Pharyngeal mass
Pneumonia
Pyrexia (fever)
Respiratory tract infection

male:

Anaphylactic reaction (serious allergic reaction)
Hypotension (abnormally low blood pressure)
Wheezing (a high-pitched whistling sound made while you breath)
Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Carotid artery occlusion (artery blockage)
Cerebral haemorrhage (bleeding within the brain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Drug ineffective
Dyspnoea (difficult or laboured respiration)

What are the common drug interactions of Vyvanse and Spiriva Respimat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Blood immunoglobulin g increased
Constipation
Dyspnoea (difficult or laboured respiration)
Ear infection
Influenza
Oropharyngeal pain
Pharyngeal mass
Pneumonia
Pyrexia (fever)
Respiratory tract infection

10-19:

Drug ineffective
Wheezing (a high-pitched whistling sound made while you breath)

20-29:

Tendon rupture (tear of tendon)
Surgery

30-39:

Anaphylactic reaction (serious allergic reaction)
Hypotension (abnormally low blood pressure)
Dyspnoea (difficult or laboured respiration)
Nausea (feeling of having an urge to vomit)

40-49:

n/a

50-59:

n/a

60+:

Anaemia (lack of blood)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Carotid artery occlusion (artery blockage)
Cerebral haemorrhage (bleeding within the brain)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 26.67%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 26.67%
Asthma: 3 people, 20.00%
Immunodeficiency: 2 people, 13.33%
Drowsiness: 2 people, 13.33%
Type 2 Diabetes: 1 person, 6.67%
Sinus Disorder (disease of sinus): 1 person, 6.67%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 6.67%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 6.67%
Neuralgia (pain in one or more nerves): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Vyvanse and Spiriva respimat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously